WHO Issues First Global Guidelines for Childhood and Adolescent Obesity

Verified Baseline

The guidance starts with structured, family-engaged care

WHO released separate guidelines for children and adolescents on Wednesday, its first global recommendations for managing obesity in these age groups. The agency strongly recommends structured dietary, physical-activity and behavior-change interventions, delivered alone or as part of a combined program. Supervised digital support receives a conditional recommendation.

The guidance is for children and adolescents who have obesity; it is not a directive to place every young person on a diet, medicine or weight-loss program. WHO says care should be age-appropriate, person-centered, attentive to mental health and focused on health, functioning and well-being—not weight alone.

The Age Divide

No weight-loss drugs or surgery for children ages 0–9

WHO does not recommend obesity medicines, bariatric surgery or weight-loss devices for children through age 9. For adolescents ages 10–19, an approved medicine may be considered only when a supervised, multimodal lifestyle program has not produced the desired result. Surgery may be considered under strict conditions for adolescents with severe obesity.

That is not a blanket endorsement of GLP-1 drugs for teenagers. Product approvals vary by country and age, and a clinician must consider eligibility, benefits, side effects, mental and physical maturity, follow-up and access. WHO said the evidence on long-term safety and effectiveness in younger patients remains limited and can change as research develops.

Why It Matters

Obesity prevalence among ages 5–19 has quadrupled since 1990

WHO estimates that 170 million children and adolescents ages 5–19 were living with obesity in 2024—70 million children ages 5–9 and 100 million adolescents ages 10–19. Prevalence rose from 2% to 8% since 1990.

Obesity is a chronic, relapsing disease associated with higher risks of type 2 diabetes and cardiovascular disease. Young people may also experience stigma, bullying, anxiety and depression. The guidance therefore calls for mental-health needs to be addressed alongside physical health without shaming a child or family.

Practical Implications

What families, clinicians and health systems can take from it

• Families: the guideline supports comprehensive professional care, not unsupervised dieting, supplements or medication bought outside clinical channels.
• Clinicians: treatment should begin with structured, developmentally appropriate support and continue over time; adolescent escalation depends on individual circumstances.
• Schools and communities: treatment alone cannot overcome unaffordable healthy food, unsafe places to be active or environments built around heavily marketed unhealthy products.
• Policymakers: WHO pairs clinical guidance with calls for fiscal, regulatory, education, transport and urban-planning measures that make healthier choices more accessible.

This article provides general reporting, not a diagnosis or a treatment recommendation for any individual child. Families should discuss growth, health risks and appropriate care with a qualified pediatric professional.

What Remains Uncertain

Evidence, access and implementation will differ by country

Verified fact: WHO prioritizes structured lifestyle and behavioral care and rules out medicines, surgery and devices for ages 0–9. Analysis: the adolescent pathway is deliberately narrower than headlines suggesting that WHO either endorsed or rejected weight-loss drugs for all minors. Forecast: national medical bodies and health systems may adapt the recommendations differently as approvals, costs and specialist capacity vary. Opinion: this report does not advocate a particular treatment or substitute for individualized medical care.